Scripps Research scientists move forward with work to study opioid alternatives
May 16, 2018
The grant, called a Merit Award, is a rare honor in biomedical research and reflects the Principal Investigator’s efforts in innovative science. With the new grant, study leader Dale Boger, PhD, Richard and Alice Cramer Professor of Chemistry at Scripps Research, and his colleagues can pursue this research for up to ten years.
The scientists are focused on understanding molecules in the brain called fatty acid amides. These molecules are important for how cells signal each other. Past studies with Scripps Research scientists Richard Lerner, MD, and Ben Cravatt, PhD, showed that a fatty acid amide called oleamide is part of how the brain naturally induces sleep. Other fatty acid amides control how the brain responds to pain and inflammation.
In fact, because some fatty acid amides are only released at injury sites, Boger and his colleagues believe they may be promising tools for studying how the body handles pain. They hope the research can provide alternative pain therapies that don’t have the same serious side effects as opioid drugs.
The grant number is 5R37DA015648.
Scripps Research awards doctoral degrees to class of 2020, celebrates graduates’ diverse scientific accomplishments
The Skaggs Graduate School of Chemical and Biological Sciences awarded doctorates to 44 young scientists who comprise the 28th graduating class at Scripps Research. In lieu of the traditional annual commencement ceremony, a virtual celebration will be held in July.
Chemist Kim Janda honored with ACS Portoghese Lectureship Award
The Medicinal Chemistry Division of ACS, along with the Journal of Medicinal Chemistry, will present Janda with the 2019 Philip S. Portoghese Medicinal Chemistry Lectureship Award to honor his many contributions to medicinal chemistry research.